{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T06:35:31Z","timestamp":1649140531544},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10165-011-0524-6","type":"journal-article","created":{"date-parts":[[2011,9,8]],"date-time":"2011-09-08T17:21:13Z","timestamp":1315502473000},"page":"353-362","source":"Crossref","is-referenced-by-count":3,"title":["Celecoxib, a cyclooxygenase-2 inhibitor, improved upper gastrointestinal lesions in rheumatoid arthritis patients as assessed by endoscopic evaluation"],"prefix":"10.1093","volume":"22","author":[{"given":"Shigeyoshi","family":"Tsuji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Nakase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Oomae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Tsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munetaka","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Edogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,9,9]]},"reference":[{"key":"524_CR1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/gast.2001.21907","volume":"120","author":"L Laine","year":"2001","unstructured":"Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology. 2001;120:594\u2013606.","journal-title":"Gastroenterology"},{"key":"524_CR2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.287.3.337","volume":"287","author":"DW Kaufman","year":"2002","unstructured":"Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA, Laine L. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287:337\u201344.","journal-title":"JAMA"},{"key":"524_CR3","first-page":"96","volume":"31","author":"Y Shiokawa","year":"1991","unstructured":"Shiokawa Y, Nobunaga M, Saito T, Asaki S, Ogawa N. Epidemiology study on upper gastrointestinal lesions induced by non-steroidal anti-inflammatory drugs (in Japanese). Ryumachi. 1991;31:96\u2013111.","journal-title":"Ryumachi"},{"issue":"1B","key":"524_CR4","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1016\/S0002-9343(98)00072-2","volume":"105","author":"G Singh","year":"1998","unstructured":"Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med. 1998;105(1B):31S\u20138S.","journal-title":"Am J Med"},{"key":"524_CR5","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","volume":"340","author":"MM Wolfe","year":"1999","unstructured":"Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med. 1999;340:1888\u201399.","journal-title":"N Engl J Med"},{"key":"524_CR6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","volume":"115","author":"SE Gabriel","year":"1991","unstructured":"Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991;115:787\u201396.","journal-title":"Ann Intern Med"},{"key":"524_CR7","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.160.14.2093","volume":"160","author":"S Hernandez-Diaz","year":"2000","unstructured":"Hernandez-Diaz S, Rodriguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding\/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med. 2000;160:2093\u20139.","journal-title":"Arch Intern Med"},{"key":"524_CR8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/s10165-002-0214-5","volume":"13","author":"T Tomita","year":"2003","unstructured":"Tomita T, Ochi T, Sugano K, Uemura S, Makuch RW. Systematic review of NSAID-induced adverse reactions in patients with rheumatoid arthritis in Japan. Mod Rheumatol. 2003;13:143\u201352.","journal-title":"Mod Rheumatol"},{"key":"524_CR9","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/rheumatology\/kei269","volume":"45","author":"E Rahme","year":"2006","unstructured":"Rahme E, Toubouti Y, Hunsche E. Therapy switching and associated costs in elderly patients receiving COX-2 selective inhibitors or non-selective non-steroidal anti-inflammatory drugs in Qubec, Canada. Rheumatology. 2006;45:903\u201310.","journal-title":"Rheumatology"},{"key":"524_CR10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/pds.653","volume":"10","author":"M Langman","year":"2001","unstructured":"Langman M, Kahler KH, Kong SX, Zhang Q, Finch E, Bentkover JD, et al. Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs. Pharmacoepidemiol Drug Saf. 2001;10:517\u201324.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"524_CR11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1099-1557(199707)6:4<263::AID-PDS286>3.0.CO;2-Z","volume":"6","author":"R Sift","year":"1997","unstructured":"Sift R, van Staa TP, Abenhaim L, Ebner D. A study of the longitudinal utilization and switching-patterns of non-steroidal anti-inflammatory drugs using a pharmacy based approach. Pharmacoepidemiol Drug Saf. 1997;6:263\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"524_CR12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0895-4356(92)90015-F","volume":"45","author":"AM Walker","year":"1992","unstructured":"Walker AM, Chan KW, Yood RA. Patterns of interchange in the dispensing of non-steroidal anti-inflammatory drugs. J Clin Epidemiol. 1992;45:187\u201395.","journal-title":"J Clin Epidemiol"},{"key":"524_CR13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1053\/j.gastro.2006.12.007","volume":"132","author":"LA Garc\u00eda Rodr\u00edguez","year":"2007","unstructured":"Garc\u00eda Rodr\u00edguez LA, Barreales Tolosa L. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology. 2007;132:498\u2013506.","journal-title":"Gastroenterology"},{"key":"524_CR14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(94)91843-0","volume":"343","author":"LA Garc\u00eda Rodr\u00edguez","year":"1994","unstructured":"Garc\u00eda Rodr\u00edguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with non-steroidal anti-inflammatory drugs. Lancet. 1994;343:769\u201372.","journal-title":"Lancet"},{"key":"524_CR15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(94)90185-6","volume":"343","author":"MJ Langman","year":"1994","unstructured":"Langman MJ, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RF, et al. Risk of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343:1075\u20138.","journal-title":"Lancet"},{"key":"524_CR16","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.282.20.1921","volume":"282","author":"LS Simon","year":"1999","unstructured":"Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, et al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA. 1999;282:1921\u20138.","journal-title":"JAMA"},{"key":"524_CR17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1572-0241.2001.03740.x","volume":"96","author":"JL Goldstein","year":"2001","unstructured":"Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, et al. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis. Am J Gastroenterol. 2001;96:1019\u201327.","journal-title":"Am J Gastroenterol"},{"key":"524_CR18","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","volume":"354","author":"P Emery","year":"1999","unstructured":"Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet. 1999;354:2106\u201311.","journal-title":"Lancet"},{"key":"524_CR19","first-page":"355","volume":"31","author":"F Wolfe","year":"2004","unstructured":"Wolfe F, Michaud K, Burke TA, Zhao SZ. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal anti-inflammatory drugs: a longitudinal study of 3639 patients in community practice. J Rheumatol. 2004;31:355\u20138.","journal-title":"J Rheumatol"},{"key":"524_CR20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/pds.909","volume":"13","author":"SZ Zhao","year":"2004","unstructured":"Zhao SZ, Wentworth C, Burke TA, Makuch RW. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs. Pharmacoepidemiol Drug Saf. 2004;13:277\u201387.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"524_CR21","first-page":"38","volume":"16","author":"C Harley","year":"2003","unstructured":"Harley C, Wagner S. Persistence with COX-2 inhibitors in managed care: an analysis of claims data. Manag Care Interface. 2003;16:38\u201345.","journal-title":"Manag Care Interface"},{"key":"524_CR22","doi-asserted-by":"crossref","unstructured":"Moride Y, Ducruet T, Rochon S, Lavoie F. Persistency of use of COX-2-specific inhibitors and non-specific non-steroidal anti-inflammatory drugs (NSAIDs) in Quebec. Rheumatology 2003;42[Suppl 3]:iii17\u201322.","DOI":"10.1093\/rheumatology\/keg494"},{"key":"524_CR23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF01536266","volume":"34","author":"MG Robinson","year":"1989","unstructured":"Robinson MG, Griffin JW Jr, Bowers J, Kogan FJ, Kogut DG, Lanza FL, et al. Effect of ranitidine gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci. 1989;34:424\u20138.","journal-title":"Dig Dis Sci"},{"key":"524_CR24","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM199605303342204","volume":"334","author":"AS Taha","year":"1996","unstructured":"Taha AS, Hudson N, Hawkey CJ, Swannell AJ, Trye PN, Cottrell J, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med. 1996;334:1435\u20139.","journal-title":"N Engl J Med"},{"key":"524_CR25","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/bmj.38232.680567.EB","volume":"329","author":"L Hooper","year":"2004","unstructured":"Hooper L, Brown TJ, Elliott R, Payne K, Roberts C, Symmons D. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review. Br Med J. 2004;329:948\u201352.","journal-title":"Br Med J"},{"key":"524_CR26","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","volume":"284","author":"FE Silverstein","year":"2000","unstructured":"Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA. 2000;284:1247\u201355.","journal-title":"JAMA"},{"key":"524_CR27","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0140-6736(07)60722-3","volume":"369","author":"JM Scheilman","year":"2007","unstructured":"Scheilman JM, Fendrick AM. Summing the risk of NSAID therapy. Lancet. 2007;369:1580\u20131.","journal-title":"Lancet"},{"key":"524_CR28","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1111\/j.1572-0241.2008.02200.x","volume":"103","author":"FK Chan","year":"2008","unstructured":"Chan FK, Abraham NS, Scheilman JM, Laine L. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First international working party on gastrointestinal and cardiovascular effects on nonsteroidal anti-inflammatory drugs and anti-platelet agents. Am J Gastroenterol. 2008;103:2908\u201318.","journal-title":"Am J Gastroenterol"},{"key":"524_CR29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","volume":"16","author":"W Zhang","year":"2008","unstructured":"Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil. 2008;16:137\u201362.","journal-title":"Osteoarthr Cartil"},{"key":"524_CR30","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(07)60749-1","volume":"369","author":"FK Chan","year":"2007","unstructured":"Chan FK, Wong VW, Suen BY, Wu JC, Ching JY, Hung LC, et al. Combination of a cyclooxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet. 2007;369:1621\u20136.","journal-title":"Lancet"},{"issue":"Suppl 2","key":"524_CR31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2036.2005.02477.x","volume":"21","author":"K Miyake","year":"2005","unstructured":"Miyake K, Ueki N, Suzuki K, Shinji Y, Kusunoki M, Hiratsuka T, et al. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine. Aliment Pharmacol Ther. 2005;21(Suppl 2):67\u201372.","journal-title":"Aliment Pharmacol Ther"},{"key":"524_CR32","unstructured":"US Food and Drug administration (FDA). Possible increased risk of bone fractures with certain antacid drugs. FDA Consumer Health Information. FDA, Washington, D.C., 2010."},{"key":"524_CR33","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s10620-005-2869-1","volume":"50","author":"G Sener","year":"2005","unstructured":"Sener G, Goren FO, Ulusoy NB, Ersoy Y, Arbak S, D\u00fclger GA. Protective effect of melatonin and omeprazole against alendronate-induced gastric damage. Dig Dis Sci. 2005;50:1506\u201312.","journal-title":"Dig Dis Sci"},{"key":"524_CR34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archinte.161.1.107","volume":"161","author":"DY Graham","year":"2001","unstructured":"Graham DY, Malaty HM. Alendronate and naproxen are synergistic for development of gastric ulcers. Arch Intern Med. 2001;161:107\u201310.","journal-title":"Arch Intern Med"},{"key":"524_CR35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00535-008-2278-2","volume":"44","author":"K Miyake","year":"2009","unstructured":"Miyake K, Kusunoki M, Shinji Y, Shindo T, Kawagoe T, Futagami S, et al. Bisphosphonate increases risk of gastroduodenal ulcer in rheumatoid arthritis patients on long-term nonsteroidal antiinflammatory drug therapy. J Gastroenterol. 2009;44:113\u201320.","journal-title":"J Gastroenterol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0524-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:27:47Z","timestamp":1646843267000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0524-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["524"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0524-6","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,9]]}}}